Masteron vs Primobolan: Which DHT Compound for a Cut?

Masteron and primobolan sit in the same corner of the compound landscape. Both are DHT derivatives, neither aromatises, and both are typically reached for on a cut or a "lean" cycle rather than a bulk. Users often ask which one to add, and the honest answer starts with the caveat that there are no controlled human trials of either compound in healthy men for lipids, haematocrit, PSA, SHBG or hair, so most of what follows is class effect, older clinical literature and community experience.

Masteron (drostanolone) is 2-alpha-methyl DHT, sold as a short-ester propionate or a longer enanthate. It is used mainly as a cosmetic finisher: a harder, drier look at low body fat, with a mild strength effect. It is generally reported to work best at low body fat, under roughly 12%, and to add little at higher body fat. It does not aromatise, and the popular claim that it lowers oestradiol is unproven (see Does Masteron Lower Estrogen?).

Primobolan (methenolone) is a 1-methyl DHT derivative that comes as an injectable enanthate and as an oral acetate. The oral form is 17-alpha-alkylated; the injectable is not. It is regarded as a mild compound that needs comparatively high weekly doses for noticeable effect, and is used for lean gains, recomp and cuts.

They overlap, they are not interchangeable, and the practical choice is often decided by supply and product authenticity rather than pharmacology.

Role on a cycle:

• Masteron: cosmetic hardening and dryness, most visible at low body fat. Commonly used in contest prep alongside testosterone.
• Primobolan: mild, steady lean gains and recomp support at higher doses, rather than a finishing agent.

Dose ranges reported in community use (not trial-derived, and the knowledge base entries for each compound give the reference figures):

• Masteron: roughly 300 to 500 mg/week, either propionate every other day or enanthate twice weekly.
• Primobolan: roughly 400 to 800 mg/week injectable enanthate for 12 to 20 weeks; oral acetate at 50 to 100 mg/day for 6 to 8 weeks is less common.

Ester and half-life:

• Masteron: propionate about 2 to 3 days, enanthate about 5 to 7 days.
• Primobolan: enanthate about 5 to 7 days, oral acetate about 4 to 6 hours.

Aromatisation and oestrogen: neither aromatises, so neither adds oestradiol. Both are frequently run on a testosterone base, and it is the testosterone that determines oestradiol. Neither has been shown to lower serum oestradiol.

Lipids: both are reported to lower HDL. The 17-alpha-alkylated oral compounds have the clearest published effect on HDL in the literature (Hartgens 2004, PMID 15155420; Friedl 1990, PMID 2294373). Primobolan injectable is generally described as the milder of the two; masteron is described as moderate, gentler than stanozolol but still HDL-suppressive. No controlled comparison exists.

SHBG: androgens in general lower SHBG (Ruokonen 1985, PMID 3160892, reported falls of 80 to 90% in anabolic steroid users). Masteron is commonly reported to lower it; primobolan's effect is thought to be smaller, but neither has been quantified in a controlled trial.

Haematocrit: erythropoiesis is androgen receptor driven rather than oestrogen driven, so a non-aromatising compound is not exempt. Neither has drostanolone or methenolone-specific data in healthy men. See How Masteron Affects Haematocrit.

Hair: both are DHT derivatives and both are widely reported on forums to accelerate hair loss in predisposed men. That is a reasonable expectation given the DHT-type structure, but controlled data on scalp hair with either compound is lacking. See TRT and hair loss: the DHT question.

HPTA suppression: both are suppressive at cycle doses and should be planned around as such.

Sourcing:

• Masteron: available through the same grey-market channels as other AAS, with the usual quality variance.
• Primobolan: widely counterfeited, because the genuine product is expensive and its effects are subtle. Vials labelled primobolan are frequently other compounds, often testosterone, masteron or boldenone.
• Australia: both have been reported as scarce. That makes product verification more important, not less.

Reasons people choose masteron:

• The goal is a hard, dry look at low body fat, for example the last weeks of a cut or contest prep
• You are already lean, since it is reported to add little at higher body fat
• You accept a moderate lipid and hair loss cost for a cosmetic benefit

Reasons people choose primobolan:

• The goal is a mild lean-gain or recomp compound with a gentler reported lipid profile
• You can verify authenticity of the product and are willing to use higher weekly doses
• You want a longer, lower-drama addition to a testosterone base

Reasons to pick neither:

• You have a family history of male pattern baldness and are already thinning
• Baseline haematocrit is high, or you have sleep apnoea, since both add androgen load
• You cannot verify the product, in which case you may be paying premium prices for something else
• You are over 40 without a baseline PSA

Whichever you choose, monitor: lipids (HDL, LDL, ApoB), haematocrit and haemoglobin at baseline, 6 to 8 weeks, then every 8 to 12 weeks, oestradiol if it drives your decisions, liver enzymes for the oral acetate, and PSA at baseline and end of cycle if you are over 40. See also How to protect your cholesterol on steroids.